Accelerating progress from advanced to early breast cancer for TNBC

Accelerating progress from advanced to early breast cancer for TNBC

Bibliographic Details
Main Author:	G. Curigliano
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977621000734

Similar Items

Accelerating progress from advanced to early breast Cancer
by: H. Rugo
Published: (2021-04-01)

Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021
by: Dario Trapani, et al.
Published: (2022-03-01)

Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
by: Jieun Lee
Published: (2023-02-01)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
by: Hoon Sik Choi, et al.
Published: (2021-08-01)

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
by: Malvina Koni, et al.
Published: (2022-08-01)

Defining triple‐negative breast cancer with neuroendocrine differentiation (TNBC‐NED)
by: Sean M Hacking, et al.
Published: (2023-07-01)

Accelerating progress from advanced to early breast cancer (SERDS, PI3Kinhibitors, other novel agents)
by: D. Cescon
Published: (2021-04-01)

Immuno-oncology treatment in early stage TNBC
by: S. Loi
Published: (2021-04-01)

The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
by: Reyhaneh Farghadani, et al.
Published: (2023-09-01)

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
by: Radhakrishnan Vishnubalaji, et al.
Published: (2021-07-01)

Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.
by: Yuko Hosokawa, et al.
Published: (2017-01-01)

Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC)
by: Yuping Liu, et al.
Published: (2018-11-01)

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022-04-01)

Recent advances in triple negative breast cancer: the immunotherapy era
by: Antonio Marra, et al.
Published: (2019-05-01)

Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple negative breast cancer (TNBC)
by: P. Krivorotko, et al.
Published: (2021-04-01)

Antiproliferative effect of Saraca asoca methanol bark extract on triple negative breast cancer (TNBC)
by: Chennattu M. Pareeth, et al.
Published: (2024-03-01)

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
by: Lijuan Weng, et al.
Published: (2024-03-01)

Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes
by: Jhajaira M. Araujo, et al.
Published: (2022-09-01)

Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts
by: Farhana Mollah, et al.
Published: (2021-12-01)

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC).
by: Shipra Gandhi, et al.
Published: (2021-03-01)

Genetic Counseling in the Follow-up of Breast Cancer patients; Conversion of a Luminal Tumor to TNBC
by: Hamid Ahmadi, et al.
Published: (2020-02-01)

P286 Quadruple Negative Breast Cancer (QNBC): outcomes in survival and comparison with the classic phenotype of TNBC
by: S. Koura, et al.
Published: (2023-03-01)

Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
by: Aiswarya Chaudhuri, et al.
Published: (2022-09-01)

The Landscape of Targeted Therapies in TNBC
by: Elena Vagia, et al.
Published: (2020-04-01)

Line of therapy adjustment in a patient with advanced triple-negative breast cancer (TNBC) by using personalized ctDNA test for treatment response monitoring
by: G. Azzi, et al.
Published: (2021-04-01)

PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
by: Yuanzhen Ma, et al.
Published: (2024-04-01)

Identification of Breast Cancer LCK Proto-Oncogene as a Master Regulator of TNBC Neutrophil Enrichment and Polarization
by: Fatma Al Qutami, et al.
Published: (2023-08-01)

Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)
by: Jiaxin Hong, et al.
Published: (2022-11-01)

Predicting Relapse in Patients With Triple Negative Breast Cancer (TNBC) Using a Deep-Learning Approach
by: Guangyuan Yu, et al.
Published: (2020-09-01)

Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines
by: Paola Maria Bonaccorsi, et al.
Published: (2019-10-01)

Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
by: Jung Ok Lee, et al.
Published: (2019-10-01)

Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
by: Aushia Tanzih Al Haq, et al.
Published: (2022-01-01)

982 Immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC)
by: Geoffrey I Shapiro, et al.
Published: (2023-11-01)

The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database
by: Kaiyan Huang, et al.
Published: (2022-04-01)

Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).
by: John Hilton, et al.
Published: (2018-01-01)

Efficacy and safety of neoadjuvant therapy for Triple-Negative Breast Cancer (TNBC): a Bayesian network meta-analysis
by: Y. Yu, et al.
Published: (2021-04-01)

Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC)
by: Jessica L. S. Zylla, et al.
Published: (2022-03-01)

1212 Bioengineered tumour-targeted interleukin-12 selectively cures murine triple-negative breast cancer (TNBC)
by: Anguraj Sadanandam, et al.
Published: (2023-11-01)

Accelerated partial breast irradiation in early stage breast cancer
by: Paulina E. Galavis, et al.
Published: (2022-11-01)

Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference
by: Michael Gnant, et al.
Published: (2022-03-01)